Next-Generation Sequencing for Screening Analysis of Cystic Fibrosis: Spectrum and Novel Variants in a South-Central Italian Cohort.
CFTR
cystic fibrosis
cystic fibrosis carriers
cystic fibrosis transmembrane conductance regulator gene
next-generation sequencing
Journal
Genes
ISSN: 2073-4425
Titre abrégé: Genes (Basel)
Pays: Switzerland
ID NLM: 101551097
Informations de publication
Date de publication:
11 08 2023
11 08 2023
Historique:
received:
22
07
2023
revised:
06
08
2023
accepted:
08
08
2023
medline:
28
8
2023
pubmed:
26
8
2023
entrez:
26
8
2023
Statut:
epublish
Résumé
The incidence of cystic fibrosis (CF) and the spectrum of cystic fibrosis transmembrane conductance regulator (CFTR) gene variants differ among geographic regions. Differences in CF carrier distribution are also reported among Italian regions. We described the spectrum of the CFTR variants observed in a large group of subjects belonging from central-southern Italy. We also provide a predictive evaluation of the novel variants identified. CFTR screening was performed in a south-central Italian cohort of 770 subjects. We adopted a next-generation sequencing (NGS) approach using the Devyser CFTR NGS kit on the Illumina MiSeq System coupled with Amplicon Suite data analysis. Bioinformatics evaluation of the impact of novel variants was described. Overall, the presence of at least one alternative allele in the CFTR gene was recorded for 23% of the subjects, with a carrier frequency of CF pathogenic variants of 1:12. The largest sub-group corresponded to the heterozygous carriers of a variant with a conflicting interpretation of pathogenicity. The common CFTR p.(Phe508del) pathogenic variants were identified in 37% of mutated subjects. Bioinformatics prediction supported a potential damaging effect for the three novel
Identifiants
pubmed: 37628659
pii: genes14081608
doi: 10.3390/genes14081608
pmc: PMC10454170
pii:
doi:
Substances chimiques
Cystic Fibrosis Transmembrane Conductance Regulator
126880-72-6
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Références
Eur Respir J. 2020 Sep 10;56(3):
pubmed: 32398304
Eur Respir J. 2020 Sep 10;56(3):
pubmed: 32912926
BMC Med Genet. 2020 May 1;21(1):89
pubmed: 32357917
Cells. 2021 Oct 22;10(11):
pubmed: 34831067
Eur Respir J. 2014 Jan;43(1):20-3
pubmed: 24381320
Genet Med. 2016 Feb;18(2):145-51
pubmed: 26087173
Health Policy. 2008 Feb;85(2):133-47
pubmed: 17728003
J Cyst Fibros. 2010 Jan;9(1):29-35
pubmed: 19897426
Expert Rev Respir Med. 2018 May;12(5):415-426
pubmed: 29580110
J Med Screen. 1997;4(4):179-80
pubmed: 9494914
J Med Case Rep. 2014 Oct 10;8:339
pubmed: 25304080
Hum Mutat. 2020 Feb;41(2):375-386
pubmed: 31674704
Bioinformatics. 2019 Jun 1;35(11):1978-1980
pubmed: 30376034
Science. 1989 Sep 8;245(4922):1073-80
pubmed: 2570460
J Cyst Fibros. 2012 Jul;11(4):281-7
pubmed: 22425241
Proc Natl Acad Sci U S A. 2020 Jan 21;117(3):1621-1627
pubmed: 31882447
Protein Sci. 2021 Jan;30(1):60-69
pubmed: 32881105
Arch Pediatr. 2020 Feb;27 Suppl 1:eS8-eS12
pubmed: 32172939
JAMA. 2009 Dec 16;302(23):2573-9
pubmed: 20009057
Am J Hum Genet. 2017 Feb 2;100(2):267-280
pubmed: 28132688
Nat Methods. 2010 Apr;7(4):248-9
pubmed: 20354512
Genet Med. 2007 Nov;9(11):739-44
pubmed: 18007142